BRIEF published on 03/25/2026 at 14:33, 1 day 8 hours ago Merck va acquérir Terns Pharmaceuticals auprès de HBM pour 6,7 milliards de dollars. Merck HBM Healthcare Acquisition Pharmaceutique Thérapie Oncologique Terns Pharmaceuticals
BRIEF published on 03/25/2026 at 14:33, 1 day 8 hours ago Merck to Acquire Terns Pharmaceuticals from HBM for $6.7 Billion Merck HBM Healthcare Pharmaceutical Acquisition Oncology Therapy Terns Pharmaceuticals
PRESS RELEASE published on 03/25/2026 at 14:28, 1 day 8 hours ago Merck to Acquire HBM Portfolio Company Terns Pharmaceuticals for USD 6.7 Billion Merck to acquire Terns Pharmaceuticals, a clinical-stage oncology company, from HBM Healthcare Investments for USD 6.7 billion. The acquisition highlights the demand for innovative therapies Acquisition Oncology Merck Innovative Therapies Terns Pharmaceuticals
BRIEF published on 03/16/2026 at 17:52, 10 days 4 hours ago HBM Healthcare Investments AG publie les chiffres clés de mars Performance Financière Valeur Nette D'actif Analyse Des Investissements Prix De L'action HBM Healthcare
BRIEF published on 03/16/2026 at 17:52, 10 days 4 hours ago HBM Healthcare Investments AG Reports March Key Figures Financial Performance Net Asset Value Share Price Investment Analysis HBM Healthcare
PRESS RELEASE published on 03/16/2026 at 17:47, 10 days 4 hours ago Key Figures 15.03.2026 HBM Healthcare Investments AG releases key performance figures for March 15, 2026, showing fluctuations in NAV and share price Performance HBM Healthcare Investments AG Key Figures Share Price NAV
BRIEF published on 03/02/2026 at 17:52, 24 days 4 hours ago HBM Healthcare Investments AG publie ses résultats mensuels Rapport Financier NAV Prix De L'action HBM Healthcare Indicateurs De Performance
BRIEF published on 03/02/2026 at 17:52, 24 days 4 hours ago HBM Healthcare Investments AG Reports Monthly Performance Figures Financial Report Share Price NAV HBM Healthcare Performance Metrics
PRESS RELEASE published on 03/02/2026 at 17:47, 24 days 4 hours ago Key Figures 28.02.2026 HBM Healthcare Investments AG reports key figures for February 2026, with NAV at 275.58 CHF and Share Price at 222.00 CHF. Performance percentages shown HBM Healthcare Investments AG Key Figures Share Price NAV February 2026
BRIEF published on 02/16/2026 at 17:51, 1 month 10 days ago HBM Healthcare Reports February 2026 Financial Performance Financial Figures Share Price NAV HBM Healthcare February 2026
Published on 03/26/2026 at 22:05, 32 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 37 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 37 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 1 hour 37 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 21:00, 1 hour 37 minutes ago Rocky Shore Closes Acquisition of Additional Mining Claims
Published on 03/26/2026 at 20:48, 1 hour 48 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 3 hours 16 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 3 hours 27 minutes ago 2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 3 hours 27 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 4 hours 20 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 4 hours 20 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 4 hours 37 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 4 hours 37 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité
